Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.33B
Enterprise Value6.27B
P/E Ratio-120.52
PEG Ratio0.75
Price/Sales Ratio26.54
Price/Book Ratio5.04
Enterprise/Revenue23
Enterprise/EBITDA-550.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.08
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue378.11M
Revenue/Share0.23
Gross Profit237.79M
EBITDA-16.23M
Net Income-80.89M
Diluted EPS-0.09

Balance Sheet

Total Cash1.65B
Total Cash/Share0.94
Total Debt24.84M
Total Debt/Equity0.01
Current Ratio5.04
Book Value Per Share1.16

Price History

52-Week Change1.7
52-Week High9.48
52-Week Low4.58
Moving Average 50 Days6.4
Moving Average 200 Days6.78

Statistics

Average Volume27.42M
Shares Outstanding1.76B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.09
Last Split Factor11:10
Last Split DateJune 23, 2016
AD